County-Level Maternal Vulnerability and Preterm Birth in the US.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 05 2023
Historique:
medline: 29 5 2023
pubmed: 25 5 2023
entrez: 25 5 2023
Statut: epublish

Résumé

Appreciation for the effects of neighborhood conditions and community factors on perinatal health is increasing. However, community-level indices specific to maternal health and associations with preterm birth (PTB) have not been assessed. To examine the association of the Maternal Vulnerability Index (MVI), a novel county-level index designed to quantify maternal vulnerability to adverse health outcomes, with PTB. This retrospective cohort study used US Vital Statistics data from January 1 to December 31, 2018. Participants included 3 659 099 singleton births at 22 plus 0/7 to 44 plus 6/7 weeks of gestation born in the US. Analyses were conducted from December 1, 2021, through March 31, 2023. The MVI, a composite measure of 43 area-level indicators, categorized into 6 themes reflecting physical, social, and health care landscapes. Overall MVI and theme were stratified by quintile (very low to very high) by maternal county of residence. The primary outcome was PTB (gestational age <37 weeks). Secondary outcomes were PTB categories: extreme (gestational age ≤28 weeks), very (gestational age 29-31 weeks), moderate (gestational age 32-33 weeks), and late (gestational age 34-36 weeks). Multivariable logistic regression quantified associations of MVI, overall and by theme, with PTB, overall and by PTB category. Among 3 659 099 births, 298 847 (8.2%) were preterm (male, 51.1%; female, 48.9%). Maternal race and ethnicity included 0.8% American Indian or Alaska Native, 6.8% Asian or Pacific Islander, 23.6% Hispanic, 14.5% non-Hispanic Black, 52.1% non-Hispanic White, and 2.2% with more than 1 race. Compared with full-term births, MVI was higher for PTBs across all themes. Very high MVI was associated with increased PTB in unadjusted (odds ratio [OR], 1.50 [95% CI, 1.45-1.56]) and adjusted (OR, 1.07 [95% CI, 1.01-1.13]) analyses. In adjusted analyses of PTB categories, MVI had the largest association with extreme PTB (adjusted OR, 1.18 [95% CI, 1.07-1.29]). Higher MVI in the themes of physical health, mental health and substance abuse, and general health care remained associated with PTB overall in adjusted models. While the physical health and socioeconomic determinant themes were associated with extreme PTB, physical health, mental health and substance abuse, and general health care themes were associated with late PTB. The findings of this cohort study suggest that MVI was associated with PTB even after adjustment for individual-level confounders. The MVI is a useful measure for county-level PTB risk that may have policy implications for counties working to lower preterm rates and improve perinatal outcomes.

Identifiants

pubmed: 37227724
pii: 2805300
doi: 10.1001/jamanetworkopen.2023.15306
pmc: PMC10214038
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2315306

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL098054
Pays : United States

Références

BMC Public Health. 2019 Feb 27;19(1):236
pubmed: 30813938
Obstet Gynecol. 2005 May;105(5 Pt 1):983-90
pubmed: 15863534
Am J Epidemiol. 2010 Jul 15;172(2):127-34
pubmed: 20576757
Pediatrics. 2008 Mar;121(3):e407-15
pubmed: 18267978
Am J Public Health. 2009 Nov;99 Suppl 3:S649-56
pubmed: 19890171
Obstet Gynecol. 2017 Oct;130(4):e187-e199
pubmed: 28937572
Pregnancy Hypertens. 2022 Dec;30:68-81
pubmed: 36029727
JAMA Cardiol. 2022 Jan 1;7(1):65-74
pubmed: 34643643
Environ Health Perspect. 2006 Aug;114(8):1150-3
pubmed: 16882517
Pediatr Crit Care Med. 2022 Aug 1;23(8):606-617
pubmed: 35604284
Obes Rev. 2015 Aug;16(8):621-38
pubmed: 26016557
J Psychosom Obstet Gynaecol. 2020 Mar;41(1):38-46
pubmed: 30624142
J Rural Health. 2007 Winter;23(1):42-8
pubmed: 17300477
J Urban Health. 2019 Apr;96(2):159-170
pubmed: 29869317
JAMA. 2022 Jan 18;327(3):248-263
pubmed: 35040888
JAMA Netw Open. 2020 Jun 1;3(6):e208243
pubmed: 32556259
Am J Obstet Gynecol MFM. 2021 Sep;3(5):100414
pubmed: 34082172
Environ Res. 2012 Aug;117:100-11
pubmed: 22726801
Environ Res. 2021 Nov;202:111654
pubmed: 34252430
BMC Pregnancy Childbirth. 2020 Apr 21;20(1):233
pubmed: 32316915
JAMA Netw Open. 2021 Oct 1;4(10):e2125373
pubmed: 34623408
BMJ. 2020 Aug 19;370:m2533
pubmed: 32816755
J Pediatr. 2013 Jan;162(1):28-34.e2
pubmed: 22878113
JAMA Netw Open. 2021 Nov 1;4(11):e2133413
pubmed: 34842927
J Perinatol. 2022 Jun;42(6):819-824
pubmed: 35132151
J Am Osteopath Assoc. 2000 Aug;100(8):485-92
pubmed: 10979253
N Engl J Med. 2007 May 24;356(21):2165-75
pubmed: 17522400
JAMA Intern Med. 2018 Dec 1;178(12):1661-1670
pubmed: 30383085
Arch Dis Child. 2019 Oct;104(10):931-935
pubmed: 30850379
Matern Child Health J. 2019 Nov;23(11):1516-1524
pubmed: 31228149
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
Pregnancy Hypertens. 2015 Oct;5(4):362-6
pubmed: 26597755
Am J Manag Care. 2013 Apr 01;19(4):e125-32
pubmed: 23725450
Intern Med J. 2021 Jan;51(1):78-86
pubmed: 32237194
J Matern Fetal Neonatal Med. 2006 Dec;19(12):773-82
pubmed: 17190687
BMJ. 2022 Feb 15;376:e064547
pubmed: 35168930
Early Hum Dev. 2016 Nov;102:47-50
pubmed: 27659865
Soc Sci Med. 1997 Jul;45(2):171-88
pubmed: 9225406
J Perinatol. 2019 Feb;39(2):286-294
pubmed: 30573752
Am J Public Health. 2022 Nov;112(11):1584-1588
pubmed: 36108250
Best Pract Res Clin Obstet Gynaecol. 2018 Oct;52:3-12
pubmed: 29779863
Lancet Diabetes Endocrinol. 2019 Sep;7(9):707-714
pubmed: 31395506
PLoS Med. 2020 Aug 18;17(8):e1003158
pubmed: 32810187
Addiction. 2016 Dec;111(12):2115-2128
pubmed: 27223595
Int J Environ Res Public Health. 2015 May 19;12(5):5355-72
pubmed: 25996888
J Perinatol. 2020 Mar;40(3):404-411
pubmed: 31235781
Paediatr Perinat Epidemiol. 2018 Sep;32(5):412-419
pubmed: 30011354
Reprod Health. 2013;10 Suppl 1:S4
pubmed: 24625215
J Urban Health. 2022 Jun;99(3):492-505
pubmed: 35384585
Int J Epidemiol. 2004 Apr;33(2):279-88
pubmed: 15082627

Auteurs

Elizabeth G Salazar (EG)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.

Diana Montoya-Williams (D)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Molly Passarella (M)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Carolyn McGann (C)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Kathryn Paul (K)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Daria Murosko (D)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Michelle-Marie Peña (MM)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.
Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia.

Robin Ortiz (R)

Department of Pediatrics, Institute for Excellence in Health Equity, NYU Grossman School of Medicine, New York, New York.
Department of Population Health, Institute for Excellence in Health Equity, NYU Grossman School of Medicine, New York, New York.

Heather H Burris (HH)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Scott A Lorch (SA)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Sara C Handley (SC)

Division of Neonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Leonard Davis Institute of Health Economics, Philadelphia, Pennsylvania.
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH